Status:
NOT_YET_RECRUITING
Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
Eurocrine Council
European Society of Endocrine Surgery (ESES)
Conditions:
Pheochromocytoma
Cardiovascular Complication
Eligibility:
All Genders
18-100 years
Brief Summary
Pheochromocytoma is an adrenomedullary chromaffin cell tumour that releases catecholamines. Adverse cardiovascular events are considered the main cause of morbidity and mortality in patients with pheo...
Detailed Description
The investigators propose a prospective, observational, multicenter, multinational study based on the EUROCRINE® registry. The study will use the my-EUROCRINE® module to add study-specific variables f...
Eligibility Criteria
Inclusion
- Patients undergoing adrenalectomy for pheochromocytoma
- Patients undergoing adrenalectomy for non-secreting tumors. Patients with non-secreting tumors are those with indication for adrenalectomy in the Eurocrine database corresponding to " excluding malignancy ".
Exclusion
- Children and minors (\<18 years).
- Pregnant women.
- Patients with other indication for adrenalectomy in Eurocrine (i.e. Adrenocortical cancer, Cushing, Primary aldosteronism, Metastasis).
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
522 Patients enrolled
Trial Details
Trial ID
NCT07200245
Start Date
October 1 2025
End Date
December 31 2027
Last Update
October 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.